Candesartan (CHARM-P) 3023 EF >40%; mean age: 67; NYHA class II–IV ... Heart failure normal ejection fraction (HFNEF) is growing at an alarming rate and has a complex pathophysiology.
Several epidemiological studies confirm that the prevalence of heart failure with normal ejection fraction is increasing. Given the current trends, heart failure with normal ejection fraction will ...
In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...
Heart failure outcomes in patients with type 2 diabetes receiving once-weekly exenatide are affected by left ventricular ejection fraction.
symptoms of NYHA class 3–4 heart failure, and low ejection fraction associated with mild left ventricular dilation, among other signs of heart dysfunction. Transmission electron micrographs of ...
CHICAGO, IL—A novel noninvasive intracardiac pressure monitoring device powered by artificial intelligence (AI) could be a ...
The mean age of participants was 77 years, 20.8% were female and 55.6% were in NYHA class III or IV. The mean LV ejection ...
The main outcome measures are cardiovascular death and the change from baseline in NYHA classification, left ventricular ejection fraction (LVEF), peak oxygen (VO2), and six-minute walk test ...
Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein =2 mg/L; p=0.003) and ischemic HFrEF etiology ...
Favorable short- and long-term outcomes are seen in patients with hypertrophic cardiomyopathy who receive septal reduction therapy.